世界の移植市場2021-2028:製品タイプ別(組織製品、免疫抑制薬)、用途別(臓器、組織移植)、最終用途別

◆英語タイトル:Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplant), By End-use, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC101
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月25日
◆ページ数:110
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の移植市場規模が2028年までに265億ドルに達すると予測しています。2021年から2028年までに年平均11.5%成長する見通しです。本調査レポートでは、移植の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品タイプ別(組織製品、免疫抑制薬、保存溶液)分析、用途別(臓器移植、組織移植)分析、最終用途別(病院、移植センター、その他)分析、地域別分析、競争状況などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・移植の世界市場規模:製品タイプ別(組織製品、免疫抑制薬、保存溶液)
・移植の世界市場規模:用途別(臓器移植、組織移植)
・移植の世界市場規模:最終用途別(病院、移植センター、その他)
・移植の世界市場規模:地域別
・競争状況
【レポートの概要】

Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 26.5 billion by 2028, growing at a CAGR of 11.5%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in high demand for transplantation procedures, which is boosting the market growth. Rising demand for transplant products, such as tissue products, immunosuppressants, and organ preservation solutions, is also a major factor driving the market. Many biotechnology and medical device companies are concentrating on the development of advanced transplant products for the management of organ failure.

Thus, technological advancement and the development of novel & improved transplant products, such as surgical instruments, have majorly contributed to the expansion of the market. In addition, the introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane, provides higher benefits during treatment. Furthermore, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports market growth.

Transplantation Market Report Highlights

• The tissue products segment accounted for the largest revenue share in 2020 due to increased demand for tissue and organ transplant procedures

• The tissue products segment is expected to expand further at a significant CAGR from 2021 to 2028 owing to the advancements in transplantation products

• The tissue transplant segment held the largest revenue share in 2020 on account of the high demand for tissue transplant procedures worldwide

• The transplant centers segment is projected to record the fastest CAGR during the forecast period owing to the rising popularity of these centers for transplant procedures

• The hospitals segment dominated the market, in terms of revenue share, in 2020 owing to a large number of transplant procedures performed in hospitals

• North America was the leading regional market in 2020 and is projected to maintain its dominance during the forecast period owing to the presence of well-developed healthcare infrastructure in the region

• The presence of a large number of research laboratories, biotechnology, and medical device companies in North America is also one of the key factors contributing to the region’s growth

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product type
1.1.2. Application type
1.1.3. End use
1.1.4. Region scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Transplantation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of organ failure
3.4.1.2. Technological advancement in transplantation method
3.4.1.3. Developed tissue banks
3.4.2. Market restraint analysis
3.4.2.1. Shortage of organ donors
3.4.2.2. Ethical and cultural issues
3.4.3. Key opportunities prioritized
3.4.3.1. Key opportunities prioritized, by Product
3.4.3.2. Key opportunities prioritized, by application
3.4.3.3. Key opportunities prioritized, by end use
3.5. Transplantation Market Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Tissue Products
4.1.1.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
4.1.2. Immunosuppressive Drugs
4.1.2.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
4.1.3. Preservation Solutions
4.1.3.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Organ Transplant
5.1.2. Tissue Transplant
5.2. Product Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Transplantation Market by Application Type Outlook
5.4.1. Organ transplant
5.4.1.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
5.4.2. Tissue transplant
5.4.2.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
Chapter 6. Transplantation Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Transplantation Centers
6.1.3. Others
6.2. Product Market Share, 2020 & 2028
6.3. Segment Dashboard
6.4. Global Transplantation Market by End Use Channel Outlook
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
6.4.2. Transplantation centers
6.4.2.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
6.4.3. Others
6.4.3.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
Chapter 7. Transplantation Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2020 & 2028
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.7.2. The U.S.
7.7.2.1. The U.S. market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.8.2. The U.K.
7.8.2.1. The U.K. market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.10. Latin America
7.10.1. market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
7.11.3. Saudi Arabia
7.11.3.1. South Africa market estimates and forecast, 2016 – 2028 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Stryker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Procedure benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Procedure benchmarking
8.3.5.4. Strategic initiatives
8.3.6. AbbVie Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Procedure benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Zimmer Biomet
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Procedure benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Novartis International AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Procedure benchmarking
8.3.8.4. Strategic initiatives
8.3.9. 21st Century Medicine
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Procedure benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biolife Solutions
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Procedure benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Teva Pharmaceutical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Procedure benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Veloxis Pharmaceuticals
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Procedure benchmarking
8.3.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America transplantation market, by region, 2026 - 2028 (Revenue, USD Billion)
Table 3 North America transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 4 North America transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 5 North America transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 6 The U.S. transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 7 The U.S. transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 8 The U.S. transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 9 Canada transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 10 Canada transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 11 Canada transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 12 Europe transplantation market, by region, 2026 - 2028 (Revenue, USD Billion)
Table 13 Europe transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 14 Europe transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 15 Europe transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 16 The U.K. transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 17 The U.K. transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 18 The U.K. transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 19 Germany transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 20 Germany transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 21 Germany transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 22 France transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 23 France transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 24 France transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 25 Italy transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 26 Italy transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 27 Italy transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 28 Spain transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 29 Spain transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 30 Spain transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 31 Asia Pacific transplantation market, by region, 2016 - 2028 (Revenue, USD Billion)
Table 32 Asia Pacific transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 33 Asia Pacific transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 34 Asia Pacific transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 35 China transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 36 China transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 37 China transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 38 Japan transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 39 Japan transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 40 Japan transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 41 Latin America transplantation market, by region, 2016 - 2028 (Revenue, USD Billion)
Table 42 Latin America transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 43 Latin America transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 44 Latin America transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 45 Brazil transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 46 Brazil transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 47 Brazil transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 48 Mexico transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 49 Mexico transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 50 Mexico transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 51 MEA transplantation market, by region, 2016 - 2028 (Revenue, USD Billion)
Table 52 MEA transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 53 MEA transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 54 MEA transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 55 South Africa transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 56 South Africa transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 57 South Africa transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)
Table 58 Saudi Arabia transplantation market, by product type, 2016 - 2028 (Revenue, USD Billion)
Table 59 Saudi Arabia transplantation market, by application, 2016 - 2028 (Revenue, USD Billion)
Table 60 Saudi Arabia transplantation market, by end use, 2016 - 2028 (Revenue, USD Billion)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Transplantation market, 2018
Fig. 14 Transplantation market segmentation
Fig. 15 Transplantation market trends
Fig. 16 Transplantation market: market driver impact
Fig. 17 Transplantation market: market restraint impact
Fig. 18 Penetration & growth prospect mapping
Fig. 19 Transplantation market– PESTLE Analysis
Fig. 20 Industry Analysis – Porter’s
Fig. 21 Transplantation market competitive landscape: Market position analysis (Based on products, regional presence)
Fig. 22 Transplantation market: Product outlook key takeaways
Fig. 23 Transplantation market: Product movement analysis
Fig. 24 Tissue products market, 2016 - 2028 (Revenue, USD Billion)
Fig. 25 Immunosuppressive drugs market, 2016 - 2028 (Revenue, USD Billion)
Fig. 26 Preservation solution market, 2016 - 2028 (Revenue, USD Billion)
Fig. 27 Transplantation market: Application movement analysis
Fig. 28 Transplantation market: 2016 - 2028 (Revenue, USD Billion)
Fig. 29 Organ transplantation market: 2016 - 2028 (Revenue, USD Billion)
Fig. 30 Tissue transplantation market: 2016 - 2028 (Revenue, USD Billion)
Fig. 31 Transplantation market: End use outlook key takeaways
Fig. 32 Transplantation market: End use movement analysis
Fig. 33 Hospitals market, 2016 - 2028 (Revenue, USD Billion)
Fig. 34 Transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 35 Others market, 2016 - 2028 (Revenue, USD Billion)
Fig. 36 Regional marketplace, 2016 - 2028 (Revenue, USD Billion)
Fig. 37 North America transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 38 The U.S. transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 39 Canada transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 40 Europe transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 41 The U.K. transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 42 Germany transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 43 France transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 44 Italy transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 45 Spain transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 46 Asia Pacific transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 47 Japan transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 48 China transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 49 Latin America transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 50 Brazil transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 51 Mexico transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 52 Middle East and Africa i transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 53 South Africa transplantation market, 2016 - 2028 (Revenue, USD Billion)
Fig. 54 Saudi Arabia transplantation market, 2016 - 2028 (Revenue, USD Billion)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の移植市場2021-2028:製品タイプ別(組織製品、免疫抑制薬)、用途別(臓器、組織移植)、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆